Orphan Drugs & Rare Diseases

How can I accelerate the development of my rare disease drug candidate?

We help you give new hope to those who are affected by rare diseases.

Quotient Sciences Logo
Articles & Publications, Dr. Paul Quigley, John McDermott

DCAT Value Chain Insights - CDMO Roundtable: Managing Orphan Drug Projects

Read More

Our goal is to help you bring new rare disease treatments to market, fast.

As a fully integrated drug development, clinical testing and manufacturing organization, Quotient Sciences addresses the challenges associated with orphan drug development. 

We are dedicated to accelerating the development of new drugs for patients around the world, providing individual services or fully integrated programs through our unique Translational Pharmaceutics® drug development platform. 

Contact us today to learn how we can help support the development and manufacturing needs of your orphan drug program.


Get in touch
Humanity can't afford to wait, so neither can we.